{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T19:52:18Z","timestamp":1771962738756,"version":"3.50.1"},"reference-count":27,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2004,10,8]],"date-time":"2004-10-08T00:00:00Z","timestamp":1097193600000},"content-version":"vor","delay-in-days":4878,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annals of Neurology"],"published-print":{"date-parts":[[1991,6]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Oral administration of proteins is a long\u2010recognized method of inducing antigen\u2010specific peripheral immune tolerance. We previously showed that oral administration of myelin basic protein suppresses monophasic experimental autoimmune encephalomyelitis in the Lewis rat when it is given in association with immunization and prior to disease onset. As a potential therapy for human autoimmune disease, it is crucial to determine whether oral tolerance can ameliorate an ongoing immune response. We therefore asked whether oral administration of myelin antigens, after sensitization and disease expression has occurred, could affect immunological, clinical, or pathological features of experimental autoimmune encephalomyelitis. Chronic relapsing experimental autoimmune encephalomyelitis was induced in the Lewis rat and strain 13 guinea pig by immunization with whole guinea pig cord homogenate, complete Freund's adjuvant, and <jats:italic>Mycobacterium tuberculosis<\/jats:italic>. Following recovery from the first attack, animals were orally given bovine myelin, guinea pig myelin, or guinea pig myelin basic protein three times per week for up to 3 months. Animals receiving myelin products orally had decreased severity and frequency of clinical relapses, decreased delayed\u2010type hypersensitivity responses to myelin antigens, diminished inflammation in the central nervous system (CNS), and decreased areas of CNS demyelination. In the rat, guinea pig myelin basic protein was as effective as guinea pig myelin in ameliorating the disease and also resulted in decreased serum anti\u2013myelin basic protein antibody levels. No exacerbation of disease or worsening of pathological findings occurred in the animals given myelin products. These results demonstrate that oral administration of myelin antigens can suppress chronic relapsing experimental autoimmune encephalomyelitis and have direct relevance to therapy of human demyelinating disorders such as multiple sclerosis.<\/jats:p>","DOI":"10.1002\/ana.410290608","type":"journal-article","created":{"date-parts":[[2005,1,1]],"date-time":"2005-01-01T12:01:19Z","timestamp":1104580879000},"page":"615-622","source":"Crossref","is-referenced-by-count":56,"title":["Suppression of experimental autoimmune encephalomyelitis by oral administration of myelin antigens: IV. Suppression of chronic relapsing disease in the lewis rat and strain 13 guinea pig"],"prefix":"10.1002","volume":"29","author":[{"given":"Staley A.","family":"Brod","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmad","family":"al\u2010Sabbagh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raymond A.","family":"Sobel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David A.","family":"Hafler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Howard L.","family":"Weiner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2004,10,8]]},"reference":[{"key":"e_1_2_1_2_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/9.2.147"},{"key":"e_1_2_1_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/0167-5699(87)90853-X"},{"key":"e_1_2_1_4_2","doi-asserted-by":"crossref","first-page":"440","DOI":"10.4049\/jimmunol.140.2.440","article-title":"Suppression of experimental autoimmune encephalomyelitis by oral administration of myelin basic protein and its fragments","volume":"140","author":"Higgins P","year":"1988","journal-title":"J Immunol"},{"key":"e_1_2_1_5_2","doi-asserted-by":"crossref","first-page":"748","DOI":"10.4049\/jimmunol.142.3.748","article-title":"Suppression of experimental autoimmune encephalomyelitis by oral administration of myelin basic protein II. Suppression of disease and in vitro immune responses is mediated by antigen\u2010specific CD8+ T lymphocytes","volume":"142","author":"Lider O","year":"1989","journal-title":"J Immunol"},{"key":"e_1_2_1_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/0008-8749(88)90305-X"},{"key":"e_1_2_1_7_2","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.4049\/jimmunol.144.5.1689","article-title":"Inhibition of S\u2010antigen induced experimental autoimmune uveoretinitis by oral induction of tolerance with S\u2010antigen","volume":"144","author":"Nussenblatt RB","year":"1990","journal-title":"J Immunol"},{"key":"e_1_2_1_8_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.83.19.7443"},{"key":"e_1_2_1_9_2","first-page":"581","article-title":"Gastric administration of Type II collagen delays the onset and severity of collagen\u2010induced arthritis","volume":"64","author":"Thompson HSG","year":"1986","journal-title":"Clin Exp Immunol"},{"key":"e_1_2_1_10_2","doi-asserted-by":"crossref","first-page":"2489","DOI":"10.4049\/jimmunol.145.8.2489","article-title":"Suppression of adjuvant arthritis in Lewis rats by oral administration of type II collagen","volume":"145","author":"Zhang ZJ","year":"1990","journal-title":"J Immunol"},{"key":"e_1_2_1_11_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410010207"},{"key":"e_1_2_1_12_2","first-page":"1693","article-title":"Animal model for multiple sclerosis. Chronic experimental allergic encephalomyelitis in inbred guinea pigs","volume":"77","author":"Raine CS","year":"1977","journal-title":"NY State J Med"},{"key":"e_1_2_1_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/0165-5728(85)90006-2"},{"key":"e_1_2_1_14_2","unstructured":"Committee on Care of Laboratory Animals of the Laboratory Research Council. National Institutes of Health no. 85\u201023 revised. Washington DC: Department of Health Education and Welfare 1985."},{"key":"e_1_2_1_15_2","doi-asserted-by":"publisher","DOI":"10.1080\/00327487208061467"},{"key":"e_1_2_1_16_2","doi-asserted-by":"publisher","DOI":"10.1159\/000233428"},{"key":"e_1_2_1_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/0008-8749(90)90097-B"},{"key":"e_1_2_1_18_2","first-page":"364","article-title":"Flare\u2010up of antigen\u2010induced arthritis in mice after challenge with oral antigen","volume":"58","author":"Lens JW","year":"1984","journal-title":"Clin Exp Immunol"},{"key":"e_1_2_1_19_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.78524"},{"key":"e_1_2_1_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/0022-510X(82)90061-2"},{"key":"e_1_2_1_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0165-5728(84)80004-1"},{"key":"e_1_2_1_22_2","doi-asserted-by":"crossref","first-page":"4464","DOI":"10.4049\/jimmunol.136.12.4464","article-title":"Treatment of esta blished chronic relapsing experimental allergic encephalomyelitis with anti\u2010L3T4 antibodies","volume":"136","author":"Sriram S","year":"1986","journal-title":"J Immunol"},{"key":"e_1_2_1_23_2","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.4049\/jimmunol.138.8.2507","article-title":"Anti\u2010T cell monoclonal antibodies in vivo II. Modulation of acute and chronic experimental allergic encephalomyelitis (EAE) in guinea pigs","volume":"138","author":"Sobel RA","year":"1987","journal-title":"J Immunol"},{"key":"e_1_2_1_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/0165-5728(87)90110-X"},{"key":"e_1_2_1_25_2","doi-asserted-by":"crossref","first-page":"909","DOI":"10.4049\/jimmunol.144.3.909","article-title":"Inhibition of murine relapsing experimental autoimmune encephalomyelitis by immune tolerance to proteolipid protein and its encephalitogenic peptides","volume":"144","author":"Kennedy MK","year":"1990","journal-title":"J Immunol"},{"key":"e_1_2_1_26_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.34.12.1615"},{"key":"e_1_2_1_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/0022-510X(79)90058-3"},{"key":"e_1_2_1_28_2","doi-asserted-by":"publisher","DOI":"10.1016\/0008-8749(90)90256-Q"}],"container-title":["Annals of Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fana.410290608","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/ana.410290608","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,23]],"date-time":"2023-10-23T00:49:23Z","timestamp":1698022163000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/ana.410290608"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1991,6]]},"references-count":27,"journal-issue":{"issue":"6","published-print":{"date-parts":[[1991,6]]}},"alternative-id":["10.1002\/ana.410290608"],"URL":"https:\/\/doi.org\/10.1002\/ana.410290608","archive":["Portico"],"relation":{},"ISSN":["0364-5134","1531-8249"],"issn-type":[{"value":"0364-5134","type":"print"},{"value":"1531-8249","type":"electronic"}],"subject":[],"published":{"date-parts":[[1991,6]]}}}